Abstract:Objective:To study the clinicopathological features of small cell invasive urothelial carcinoma and the differential diagnosis of the other small cell lesions of bladder biopsy.Methods: Pathological and clinical data of 1 case of small cell invasive urothelial carcinoma were retrospectively analyzed and relevant literatures from China and abroad were reviewed.Results: Male, 82 years old, cystoscope: in the neck of the bladder 10~12 mucosal protrusions such as mushroom, pedicle was not obvious. Morphological features of bladder biopsy tissue under light microscope were: 1) diffuse and nested distribution of subcutaneous small cell tumor cells in the urinary tract, interstitial proliferation; 2) the cells were small, with short fusiform or lymphoid, very little cytoplasm, the local tumor cell cytoplasm was broad and transparent; 3) the nuclei were round, oval or fusiform, nuclear hyperchromatism and structure were not clear, dual core, nuclear overlap and multinucleated giant tumor cell, prominent nucleoli were not seen; 4) no mitotic figures; 5) local tissue extrusion phenomenon and focal coagulation necrosis; 6) vascular invasion; 7) local dysplasia in urinary tract epithelial basal layer and components of small cell tumor in intrinsic membrane were transitional. Immunohistochemistry, a few cells CK weak (+), the remaining markers were (?); pathological diagnosis: small cell undifferentiated carcinoma. Transurethral resection of bladder tumor, no pathology, mesenteric multiple metastatic tumor nodules were found several months later, the morphology of the tumor cells was similar to that of bladder biopsy, the local tumor cell nuclei deviation, visible nucleoli and pathological mitotic figures. Immunohistochemistry, epithelial markers, p63 and CD44V6 were positive, neuroendocrine markers still were negative. Comprehensive consideration of final pathological diagnosis was bladder small cell invasive urothelial carcinoma with intestinal wall metastasis.Conclusion:hTe diagnosis of small cell malignant tumor in bladder biopsy specimen was diffcult. We should pay more attention to its pathological features. Differential diagnosis should be combined with clinical and immunohistochemical characteristics. When the two can’t provide valuable help, the diagnosis should be based on the morphology of HE slices, and it was also indicated in the report. Nuclear mitotic ifgures should be with or without in the pathologic diagnosis of urinary tract epithelial carcinoma of the bladder biopsy specimen.

The application of immunohistochemical biomarkers in urologic surgical pathology.

Application of Immunohistochemistry in Undifferentiated Neoplasms: A Practical Approach.

Utility of immunohistochemistry in the pancreatobiliary tract.

Practical Immunohistochemistry In Neoplastic Pathology Of The Gastrointestinal Tract, Liver, Biliary Tract, And Pancreas

Enhancing upper tract urothelial carcinoma diagnosis: Utility of cytokeratin 17 and CK20/CD44/p53 immunohistochemical panel

Immunohistochemistry In Undifferentiated Neoplasm/Tumor Of Uncertain Origin

Application Of Immunohistochemistry In Gastrointestinal And Liver Neoplasms New Markers And Evolving Practice

Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors

Recent Advances in Imaging-Guided Interventions for Prostate Cancers.

Diagnostic Approach to and Differential Diagnosis of Clear Cell and Glandular Lesions of the Lower Urinary Tract

Use of Immunohistochemistry in Routine Workup of Prostate Needle Biopsies: A Tertiary Academic Institution Experience

Diagnosis and differential diagnosis of small cell invasive urothelial carcinoma of bladder biopsy with easy to be confused：a case report

Common Diagnostic Challenges in Genitourinary Mesenchymal Tumors: A Practical Approach

Applications of radiomics in genitourinary tumors

The evolving landscape of immunohistochemistry in cervical and uterine carcinoma in gynecologic oncology: current status and future directions

The Role of Immunohistochemistry as a Surrogate Marker in Molecular Subtyping and Classification of Bladder Cancer

Clinicopathologic Study on Plasmacytoid Urothelial Carcinoma of Bladder

The combined application of urinary liquid-based cytology with fluorescence in situ hybridization and p16/Ki-67 dual immunostaining is valuable for improving the early diagnosis of upper tract urothelial carcinomas

Precision in Diagnostic Molecular Pathology based on Immunohistochemistry.

Immunohistochemistry as a diagnostic aid in cervical pathology

[Several Key and Difficult Issues Related to the Grading of Urothelial Carcinoma of Urinary Bladder].